Anti-Human CD52 Recombinant Antibody(Tarextumab)
-
产品编号
YR1312
-
别名
科研级 Tarextumab ( 他瑞妥单抗 ), Anti-CD52 Recombinant Antibody, Research Grade Tarextumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Tarextumab ( 他瑞妥单抗 ), Anti-CD52 Recombinant Antibody, Research Grade Tarextumab |
| Catalog Number | YR1312 |
| Molecular Name | Tarextumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG2 Kappa Lambda |
| Formulation | PBS, pH7.5 |
| Background | Tarextumab (formerly OMP-59R5) is a fully human monoclonal antibody targeting the Notch 2/3 receptors. It is being tested as a possible treatment for cancer. In January 2015, the US FDA granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and lung cancer. Two early stage clinical trials have reported encouraging results. |
| CAS Number | 1359940-55-8 |
| Application | IF, IP, Neut, FuncS, ELISA, FCM |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | CD52[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
